Role of MMP14 gene polymorphisms in susceptibility and pathological development to hepatocellular carcinoma

Annals of Surgical Oncology

Volumn 18, Issue 8, 2011, Pages 2348-2356

  Chen, Tzy Yen ^a,b   Li, Yi Ching ^a,b   Liu, Yu Fan ^a   Tsai, Chiung Man ^c   Hsieh, Yi Hsien ^a   Lin, Chiao Wen ^a   Yang, Shun Fa ^a,b   Weng, Chia Jui ^d  

^a CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^b CHUNG SHAN MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^c Chest Hospital   (Taiwan)

^d TAINAN UNIVERSITY OF TECHNOLOGY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

MATRIX METALLOPROTEINASE 14;

ADULT; AGED; ARTICLE; CANCER PATIENT; CANCER RISK; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENOTYPE; HAPLOTYPE; HOMOZYGOTE; HUMAN; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISM; WILD TYPE;

CARCINOMA, HEPATOCELLULAR; CASE-CONTROL STUDIES; DNA, NEOPLASM; FEMALE; FOLLOW-UP STUDIES; GENOTYPE; HUMANS; LIVER NEOPLASMS; LYMPHATIC METASTASIS; MALE; MATRIX METALLOPROTEINASE 14; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; POLYMORPHISM, SINGLE NUCLEOTIDE; REAL-TIME POLYMERASE CHAIN REACTION; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 80051552454     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-011-1574-x     Document Type: Article

References (43)

1. Y Itoh M Seiki 2006 MT1-MMP: a potent modifier of pericellular microenvironment J Cell Physiol. 1 1 8 10.1002/jcp.20431 1:CAS:528: DC%2BD1cXltlejsb0%3D (Pubitemid 41740711)
2. CJ Weng GC Yen 2010 The in vitro and in vivo experimental evidences disclose the chemopreventive effects of Ganoderma lucidum on cancer invasion and metastasis Clin Exp Metastasis. 27 361 369 20461449 10.1007/s10585-010-9334-z
3. K Ohnishi M Takagi Y Kurokawa S Satomi YT Konttinen 1998 Matrix metalloproteinase-mediated extracellular matrix protein degradation in human pulmonary emphysema Lab Invest. 78 1077 1087 9759652 1:STN:280: DyaK1cvjtVCmsA%3D%3D (Pubitemid 28440824)
4. Y Jo J Yeon HJ Kim ST Lee 2000 Analysis of tissue inhibitor of metalloproteinases-2 effect on pro-matrix metalloproteinase-2 activation by membrane-type 1 matrix metalloproteinase using baculovirus/insect-cell expression system Biochem J. 345 511 519 10642509 10.1042/0264-6021:3450511 1:CAS:528:DC%2BD3cXisFOlsbk%3D (Pubitemid 30099080)
5. M Furuya H Ishikura R Nemori M Shibata S Fujimoto T Yoshiki 2001 Clarification of the active gelatinolytic sites in human ovarian neoplasms using in situ zymography Human Pathol. 32 163 168 10.1053/hupa.2001.21558 1:CAS:528:DC%2BD3MXit1ersr0%3D (Pubitemid 32193714)
6. Y Li T Aoki Y Mori M Ahmad H Miyamori T Takino H Sato 2004 Cleavage of lumican by membrane-type matrix metalloproteinase-1 abrogates this proteoglycan-mediated suppression of tumor cell colony formation in soft agar Cancer Res. 64 7058 7064 15466200 10.1158/0008-5472.CAN-04-1038 1:CAS:528:DC%2BD2cXotFalsb8%3D (Pubitemid 39331017)
7. F Sabeh I Ota K Holmbeck, et al. 2004 Tumor cell traffic through the extracellular matrix is controlled by the membrane-anchored collagenase MT1-MMP J Cell Biol. 167 769 781 15557125 10.1083/jcb.200408028 1:CAS:528: DC%2BD2cXhtVaqtb3J (Pubitemid 39565156)
8. HG Munshi YI Wu S Mukhopadhyay, et al. 2004 Differential regulation of membrane type 1 matrix metalloproteinase activity by ERK1/2 and p38 MAPK-modulated tissue inhibitor of metalloproteinases 2 expression controls transforming growth factor b1-induced pericellular collagenolysis J Biol Chem. 279 39042 39050 15247230 10.1074/jbc.M404958200 1:CAS:528:DC%2BD2cXnt1yjsbs%3D (Pubitemid 39296066)
9. MV Barbolina BP Adley EV Ariztia Y Liu MS Stack 2007 Microenvironmental regulation of membrane type I matrix metalloproteinase activity in ovarian carcinoma cells via collagen-induced EGR1 expression J Biol Chem. 282 4924 4931 17158885 10.1074/jbc.M608428200 1:CAS:528:DC%2BD2sXhsFKgt74%3D (Pubitemid 47100955)
10. KB Hotary ED Allen PC Brooks NS Datta MW Long SJ Weiss 2003 Membrane type 1 matrix metalloproteinase usurps tumor growth control imposed by the three-dimensional extracellular matrix Cell. 114 33 45 12859896 10.1016/S0092-8674(03)00513-0 1:CAS:528:DC%2BD3sXlslWqsbY%3D (Pubitemid 36859839)
11. X Chen ST Cheung S So, et al. 2002 Gene expression patterns in human liver cancers Mol Biol Cell. 13 1929 1939 12058060 10.1091/mbc.02-02-0023. 1:CAS:528:DC%2BD38XltVWqsbc%3D (Pubitemid 34651483)
12. AK Sood MS Fletcher JE Coffin, et al. 2004 Functional role of matrix metalloproteinases in ovarian tumor cell plasticity Am J Obstet Gynecol. 190 899 909 15118611 10.1016/j.ajog.2004.02.011 1:CAS:528:DC%2BD2cXkvVGlsbk%3D (Pubitemid 38561505)
13. B Davidson I Goldberg WH Gotlieb J Kopolovic G Ben-Baruch JM Nesland R Reich 2002 The prognostic value of metalloproteinases and angiogenic factors in ovarian carcinoma Mol Cell Endocrinol. 187 39 45 11988310 10.1016/S0303-7207(01) 00709-2 1:CAS:528:DC%2BD38Xjt1SqsLk%3D (Pubitemid 34436931)
14. Z Zhou SS Apte R Soininen, et al. 2000 Impaired endochondral ossification and angiogenesis in mice deficient in membrane-type matrix metalloproteinase I Proc Natl Acad Sci USA. 97 4052 4057 10737763 10.1073/pnas.060037197 1:CAS:528:DC%2BD3cXislSgtLo%3D (Pubitemid 30226085)
15. M Seiki 2003 Membrane-type 1 matrix metalloproteinase: a key enzyme for tumor invasion Cancer Lett. 194 1 11 12706853 10.1016/S0304-3835(02)00699-7 1:CAS:528:DC%2BD3sXjtFCjs7o%3D (Pubitemid 36428879)
16. BS Shastry 2002 SNP alleles in human disease and evolution J Hum Genet. 47 561 566 12436191 10.1007/s100380200086 1:CAS:528:DC%2BD38XoslOru78%3D (Pubitemid 36083255)
17. CJ Weng YH Hsieh CM Tsai, et al. 2010 Relationship of insulin-like growth factors system gene polymorphisms with the susceptibility and pathological development of hepatocellular carcinoma Ann Surg Oncol. 17 1808 1815 20119675 10.1245/s10434-009-0904-8
18. PA Farazi RA DePinho 2006 Hepatocellular carcinoma pathogenesis: from genes to environment Nat Rev Cancer. 6 674 687 16929323 10.1038/nrc1934 1:CAS:528:DC%2BD28XosVOmsLs%3D (Pubitemid 44286000)
19. Firpi RJ, Nelson DR. Viral hepatitis: manifestations and management strategy. Hematol Am Soc Hematol Educ Program. 2006;375-80.
20. Y Yano F Yamashita K Kuwaki, et al. 2006 Clinical features of hepatitis C virus-related hepatocellular carcinoma and their association with alpha-fetoprotein and protein induced by vitamin K absence or antagonist-II Liver Int. 26 789 795 16911460 10.1111/j.1478-3231.2006.01310.x 1:CAS:528:DC%2BD28XhtVegsrvL (Pubitemid 44165246)
21. CJ Weng CM Tsai YC Chen, et al. 2010 Evaluation of the association of urokinase plasminogen activator system gene polymorphisms with susceptibility and pathological development of hepatocellular carcinoma Ann Surg Oncol 17 3394 3401 20706793 10.1245/s10434-010-1124-y
22. MA Feitelson 2006 Parallel epigenetic and genetic changes in the pathogenesis of hepatitis virus-associated hepatocellular carcinoma Cancer Lett. 239 10 20 16154256 10.1016/j.canlet.2005.07.009 1:CAS:528:DC%2BD28Xms1agtrs%3D (Pubitemid 43949592)
23. SS Thorgeirsson JW Grisham 2002 Molecular pathogenesis of human hepatocellular carcinoma Nat Genet. 31 339 346 12149612 10.1038/ng0802-339 1:CAS:528:DC%2BD38Xls1Oku7c%3D (Pubitemid 35154440)
24. JC de Vicente P Lequerica-Fernández J Santamaría MF Fresno 2007 Expression of MMP-7 and MT1-MMP in oral squamous cell carcinoma as predictive indicator for tumor invasion and prognosis J Oral Pathol Med. 36 415 424 17617835 10.1111/j.1600-0714.2007.00546.x (Pubitemid 47037904)
25. CJ Chen MW Yu YF Liaw 1997 Epidemiological characteristics and risk factors of hepatocellular carcinoma J Gastroenterol Hepatol. 12 S294 S308 9407350 10.1111/j.1440-1746.1997.tb00513.x 1:STN:280:DyaK1c%2FntFansw%3D%3D
26. TH Chen CJ Chen MF Yen, et al. 2002 Ultrasound screening and risk factors for death from hepatocellular carcinoma in a high-risk group in Taiwan Int J Cancer. 98 257 261 11857416 10.1002/ijc.10122 1:CAS:528:DC%2BD38XhsVSkuro%3D (Pubitemid 34150810)
27. MC Tsai KM Kee YD Chen LC Lin LS Tsai HH Chen SN Lu 2007 Excess mortality of hepatocellular carcinoma and morbidity of liver cirrhosis and hepatitis in HCV-endemic areas in an HBV-endemic country: geographic variations among 502 villages in southern Taiwan J Gastroenterol Hepatol. 22 92 98 17201888 10.1111/j.1440-1746.2006.04489.x (Pubitemid 44953423)
28. H AkkIz S Bayram A Bekar, et al. 2009 G-308A TNF-alpha polymorphism is associated with an increased risk of hepatocellular carcinoma in the Turkish population: case-control study Cancer Epidemiol. 33 261 264 19683483 10.1016/j.canep.2009.06.001
29. CC Chang SC Chen YH Hsieh, et al. 2009 Stromal cell-derived factor-1 but not its receptor, CXCR4, gene variants increase susceptibility and pathological development of hepatocellular carcinoma Clin Chem Lab Med. 47 412 418 19327121 10.1515/CCLM.2009.092 1:CAS:528:DC%2BD1MXlvVGgsLk%3D
30. MA Buendia 2000 Genetics of hepatocellular carcinoma Semin Cancer Biol. 10 185 200 10936068 10.1006/scbi.2000.0319 1:STN:280:DC%2BD3M%2Fjtlyruw%3D%3D (Pubitemid 30614220)
31. YC Ip ST Cheung KL Leung ST Fan 2005 Mechanism of metastasis by membrane type 1-matrix metalloproteinase in hepatocellular carcinoma World J Gastroenterol. 11 6269 6276 16419154 1:CAS:528:DC%2BD28XntVeqtA%3D%3D
32. YC Ip ST Cheung ST Fan 2007 A typical localization of membrane type 1-matrix metalloproteinase in the nucleus is associated with aggressive features of hepatocellular carcinoma Mol Carcinog. 46 225 230 17219425 10.1002/mc.20270 1:CAS:528:DC%2BD2sXjtFCitr0%3D (Pubitemid 46399521)
33. T Harada S Arii M Mise, et al. 1998 Membrane-type matrix metalloproteinase-1(MT1-MTP) gene is overexpressed in highly invasive hepatocellular carcinomas J Hepatol. 28 231 239 9514536 10.1016/0168-8278(88) 80010-2 1:CAS:528:DyaK1cXmvVWgs70%3D (Pubitemid 28116431)
34. M Maatta Y Soini A Liakka H Autio-Harmainen 2000 Differential expression of matrix metalloproteinase (MMP)-2, MMP-9, and membranetype1-MMP in hepatocellular and pancreatic adenocarcinoma: Implications for tumor progression and clinical prognosis Clin Cancer Res. 6 2726 2734 10914717 1:CAS:528:DC%2BD3cXlslent7Y%3D (Pubitemid 30482111)
35. W Saitoh T Sakamoto AE Hegab, et al. 2006 MMP14 gene polymorphisms in chronic obstructive pulmonary disease Int J Mol Med. 17 621 626 16525718 1:CAS:528:DC%2BD28XjsVyisb8%3D
36. A Miyoshi Y Kitajima S Kido T Shimonishi S Matsuyama K Kitahara K Miyazaki 2005 Snail accelerates cancer invasion by upregulating MMP expression and is associated with poor prognosis of hepatocellular carcinoma Br J Cancer. 92 252 258 15668718 1:CAS:528:DC%2BD2MXhtFWhurk%3D (Pubitemid 40343137)
37. VS Golubkov S Boyd AY Savinov, et al. 2005 Membrane type-1 matrix metalloproteinase (MT1-MMP) exhibits an important intracellular cleavage function and causes chromosome instability J Biol Chem. 280 25079 25086 15878869 10.1074/jbc.M502779200 1:CAS:528:DC%2BD2MXlsFyqtrY%3D (Pubitemid 40934599)
38. BE Wang WM Ma A Sulaiman, et al. 2002 Demographic, clinical, and virological characteristics of hepatocellular carcinoma in Asia: survey of 414 patients from four countries J Med Virol. 67 394 400 12116033 10.1002/jmv.10087 (Pubitemid 34569080)
39. KB Schwarz 1996 Oxidative stress during viral infection: a review Free Radical Biol Med. 21 641 649 10.1016/0891-5849(96)00131-1 1:CAS:528: DyaK28Xmt12lsbc%3D (Pubitemid 26331094)
40. A Mansouri B Fromenty A Berson, et al. 1997 Multiple hepatic mitochondrial DNA deletions suggest premature oxidative aging in alcoholic patients J Hepatol. 27 96 102 9252080 10.1016/S0168-8278(97)80286-3 1:CAS:528:DyaK2sXltVOrs7c%3D (Pubitemid 27357061)
41. I Merican R Guan D Amarapuka, et al. 2000 Chronic hepatitis B virus infection in Asian countries J Gastroenterol Hepatol 15 1356 1361 11197043 10.1046/j.1440-1746.2000.0150121356.x 1:STN:280:DC%2BD3M7jvFCitw%3D%3D (Pubitemid 32052906)
42. D Lavanchy 2004 Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures J Viral Hepatitis. 11 97 107 10.1046/j.1365-2893.2003.00487.x 1:STN:280: DC%2BD2c7gs1Whug%3D%3D (Pubitemid 38365759)
43. S Shifman M Bronstein M Sternfeld, et al. 2002 A highly significant association between a COMT haplotype and schizophrenia Am J Hum Genet. 71 1296 1302 12402217 10.1086/344514 1:CAS:528:DC%2BD3sXjsV2m (Pubitemid 36015884)